Efficacy and Tolerability of Topical LFX453 for External Genital Warts

Clinical trial NCT02482428 · COMPLETED

Trial details

NCT number: NCT02482428
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

External Genital Warts

Start date: 2015-05-12
Primary completion: 2016-05-31
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.